| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Obstetrics and Gynecology, CSMC Burns and Allen Research Institute, University of California School of Medicine (S.R.W., A.N., D.A.M.), Los Angeles, California 90048-0750; and Department of Obstetrics and Gynecology, Second Clinic of Surgical Gynecology, University School of Medicine (A.J.J.), 20-090 Lublin, Poland
Address all correspondence and requests for reprints to: Dr. Denis A. Magoffin, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Davis 2066, Los Angeles, California 90048-0750. E-mail: magoffin{at}cshs.org
Recent data suggest that steroidogenic enzyme messenger ribonucleic
acids (mRNAs) may be overexpressed in thecal cells, and LH receptors
may be prematurely expressed in granulosa cells in women with
polycystic ovaries. The purpose of this study was to determine whether
there is abnormal gene expression in thecal and granulosa cells from
polycystic ovaries. Ovarian tissue specimens were obtained from 12
women with PCOS and 24 regularly cycling control women. The granulosa
cells and the theca interna were microdissected from individual
follicles. LH receptor, steroidogenesis acute regulatory protein
(StAR), cholesterol side-chain cleavage cytochrome P450 (CYP11A), and
17
-hydroxylase/C1720 lyase cytochrome P450 (CYP17)
mRNAs were measured by RT-PCR. There was no difference between 3- to
7-mm control follicles and dominant follicles with respect to LH
receptor mRNA expression in either thecal or granulosa cells. CYP11A
and CYP17 mRNAs were higher in thecal cells from 3- to 7-mm follicles
than in dominant follicles, but StAR expression was not different. In
granulosa cells, StAR and CYP11A mRNA expression was higher in dominant
follicles than in 3- to 7-mm follicles. The mean levels of LH receptor,
StAR, CYP11A, and CYP17 mRNA expression were higher in thecal cells
from PCOS follicles than in size-matched control follicles. In
granulosa cells, the mean levels of LH receptor and CYP11A, but not
StAR, mRNA expression were higher in PCOS than in control follicles.
These data demonstrate that regulatory protein and steroidogenic enzyme
mRNAs are overexpressed in thecal and granulosa cells from polycystic
ovaries and support the conclusions that the thecal cells are
hyperstimulated and the granulosa cells may be prematurely luteinizing.
This article has been cited by other articles:
![]() |
S. Catteau-Jonard, S. P. Jamin, A. Leclerc, J. Gonzales, D. Dewailly, and N. di Clemente Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4456 - 4461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Das, D.J. Gillott, E. Saridogan, and O. Djahanbakhch Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome Hum. Reprod., September 1, 2008; 23(9): 2122 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Das, O. Djahanbakhch, B. Hacihanefioglu, E. Saridogan, M. Ikram, L. Ghali, M. Raveendran, and A. Storey Granulosa Cell Survival and Proliferation Are Altered in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 881 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Moran, M. Noakes, P. M. Clifton, and R. J. Norman The Use of Anti-Mullerian Hormone in Predicting Menstrual Response after Weight Loss in Overweight Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3796 - 3802. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Munir, H.-W. Yen, T. Baruth, R. Tarkowski, R. Azziz, D. A. Magoffin, and A. J. Jakimiuk Resistin Stimulation of 17{alpha}-Hydroxylase Activity in Ovarian Theca Cells in Vitro: Relevance to Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4852 - 4857. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jansen, J. S. E. Laven, H. B. R. Dommerholt, J. Polman, C. van Rijt, C. van den Hurk, J. Westland, S. Mosselman, and B. C. J. M. Fauser Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients Mol. Endocrinol., December 1, 2004; 18(12): 3050 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. R. Maciel, E. C. Baracat, J. A. Benda, S. M. Markham, K. Hensinger, R. J. Chang, and G. F. Erickson Stockpiling of Transitional and Classic Primary Follicles in Ovaries of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5321 - 5327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Phy, C. A. Conover, D. H. Abbott, M. A. Zschunke, D. L. Walker, D. R. Session, I. S. Tummon, A. R. Thornhill, T. G. Lesnick, and D. A. Dumesic Insulin and Messenger Ribonucleic Acid Expression of Insulin Receptor Isoforms in Ovarian Follicles from Nonhirsute Ovulatory Women and Polycystic Ovary Syndrome Patients J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3561 - 3566. [Abstract] [Full Text] [PDF] |
||||
![]() |
H-W. Yen, A.J. Jakimiuk, I. Munir, and D.A. Magoffin Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries Mol. Hum. Reprod., July 1, 2004; 10(7): 473 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gaasenbeek, B. L. Powell, U. Sovio, L. Haddad, N. Gharani, A. Bennett, C. J. Groves, K. Rush, M. J. Goh, G. S. Conway, et al. Large-Scale Analysis of the Relationship between CYP11A Promoter Variation, Polycystic Ovarian Syndrome, and Serum Testosterone J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2408 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jonard and D. Dewailly The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest Hum. Reprod. Update, March 1, 2004; 10(2): 107 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Munir, H.-W. Yen, D. H. Geller, D. Torbati, R. M. Bierden, S. R. Weitsman, S. K. Agarwal, and D. A. Magoffin Insulin Augmentation of 17{alpha}-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase But Not Extracellular Signal-Regulated Kinase-1/2 in Human Ovarian Theca Cells Endocrinology, January 1, 2004; 145(1): 175 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Loumaye, P. Engrand, Z. Shoham, S.G. Hillier, and D.T. Baird Clinical evidence for an LH ceiling? Hum. Reprod., December 1, 2003; 18(12): 2719 - 2720. [Full Text] [PDF] |
||||
![]() |
D. Nogueira, C. Albano, T. Adriaenssens, R. Cortvrindt, C. Bourgain, P. Devroey, and J. Smitz Human Oocytes Reversibly Arrested in Prophase I by Phosphodiesterase Type 3 Inhibitor In Vitro Biol Reprod, September 1, 2003; 69(3): 1042 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Couse, M. M. Yates, V. R. Walker, and K. S. Korach Characterization of the Hypothalamic-Pituitary-Gonadal Axis in Estrogen Receptor (ER) Null Mice Reveals Hypergonadism and Endocrine Sex Reversal in Females Lacking ER{alpha} But Not ER{beta} Mol. Endocrinol., June 1, 2003; 17(6): 1039 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Jakimiuk, S. R. Weitsman, H.-W. Yen, M. Bogusiewicz, and D. A. Magoffin Estrogen Receptor {alpha} and {beta} Expression in Theca and Granulosa Cells from Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5532 - 5538. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |